Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Viking Holdings Ltd Ordinary Shares (VIK) Price & Performance

Halozyme Therapeutics Inc. Common StockTrade
Viking Holdings Ltd Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Halozyme Therapeutics Inc. Common Stock vs Viking Holdings Ltd Ordinary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.94 (market cap $12.58B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.46B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 2.9× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Viking Holdings Ltd Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.

HALOVIK
Market Cap
$12.58B$36.46B
Volume
2,179,2783,461,906
Sector
HealthConsumer Cyclical
52-Week High
$115.22$108.26
52-Week Low
$61.63$57.08
Typical Hold Time
0 Days0 Days
Enterprise Value
$14.49B$38.84B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HALO
100% Buy0% Sell
Avg holding period · 0 Days
VIK
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →

About Viking Holdings Ltd Ordinary Shares

Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.

Read more on VIK →